Jiang Yongwen, McDonald James V, Koziol Jennifer, McCormick Meghan, Viner-Brown Samara, Alexander-Scott Nicole
Center for Health Data and Analysis, Rhode Island Department of Health, Providence, Rhode Island (Dr Jiang and Ms Viner-Brown); Department of Epidemiology, School of Public Health, Brown University, Providence, Rhode Island (Dr Jiang); Board of Medical Licensure and Discipline, Board Certified Pediatrics and Preventive Medicine, Rhode Island Department of Health, Providence, Rhode Island (Dr McDonald); Prescription Drug Overdose Prevention Program, Center for Health Promotion, Rhode Island Department of Health, Providence, Rhode Island (Mss Koziol and McCormick); Department of Health, Providence, Rhode Island (Dr Alexander-Scott); Department of Pediatrics and Medicine, Warren Alpert Medical School, Brown University, Providence, Rhode Island (Dr Alexander-Scott).
J Public Health Manag Pract. 2017 Sep/Oct;23(5):499-506. doi: 10.1097/PHH.0000000000000514.
Drug overdoses are a growing public health problem in the United States. Rhode Island is also confronted with a serious epidemic of drug overdose deaths and ranks sixth worst in the United States for age-adjusted drug overdose death rate.
To monitor trends of drug overdose-related emergency department (ED) visits, hospitalizations, and deaths and classify the drug overdoses by demographics, discharge status, intent, and specific drug involved to plan for health care resource allocation, mental health services, drug abuse treatment, prevention, and policies.
Cross-sectional study.
The 2005-2014 ED, hospital discharge, and death data were used for this study.
Age-adjusted rates were calculated by using age-specific Rhode Island 2010 standard population. Healthcare Cost and Utilization Project cost-to-charge ratios were used to convert total hospital charges to costs. The descriptive analysis was performed.
Hospitalizations generally represent the most severe cases; there are substantially fewer cases than are seen in the ED, and their characteristics are different from ED visits. More than half of the ED cases were an unintentional injury by drug overdose, but more than half of the hospital discharge data cases were a suicide/self-inflicted injury by drug overdose. There were typically much more females than males that result in a hospital admission. In Rhode Island, there were 249 drug overdose deaths in 2014. Drug overdose fatalities were more likely to be young, male, white, and those who reside in suburban regions.
Nonfatal and fatal drug overdose data are important for understanding the scope, incidence, and breadth of this public health epidemic and can guide overdose intervention efforts. In Rhode Island, policy makers can use drug overdose data to target high-risk subpopulations to reduce overdose injuries and fatalities. The Rhode Island study can be shared with other states.
Regardless of the type of drug, overdoses remain a public health crisis in Rhode Island. It is a dynamic epidemic and needs partnership among public health, behavioral health, public safety, clinic, pharmacy, and communities. The ability to track drug overdose in real time will be an essential tool to respond to the constantly evolving drug overdose epidemic in Rhode Island quickly and effectively.
药物过量在美国是一个日益严重的公共卫生问题。罗德岛也面临着药物过量死亡的严重流行,在按年龄调整的药物过量死亡率方面在美国排名第六。
监测与药物过量相关的急诊科就诊、住院和死亡趋势,并按人口统计学、出院状态、意图和涉及的具体药物对药物过量进行分类,以规划医疗资源分配、心理健康服务、药物滥用治疗、预防和政策。
横断面研究。
本研究使用了2005 - 2014年的急诊科、医院出院和死亡数据。
使用罗德岛2010年特定年龄标准人口计算年龄调整率。使用医疗保健成本和利用项目成本与收费比率将医院总收费转换为成本。进行描述性分析。
住院通常代表最严重的病例;病例数量比急诊科的少得多,且其特征与急诊科就诊不同。超过一半的急诊科病例是药物过量导致的意外伤害,但超过一半的医院出院数据病例是药物过量导致的自杀/自我伤害。导致住院的女性通常比男性多得多。2014年罗德岛有249例药物过量死亡。药物过量死亡更可能发生在年轻人、男性、白人以及居住在郊区的人群中。
非致命和致命药物过量数据对于了解这一公共卫生流行的范围、发病率和广度很重要,并且可以指导过量干预措施。在罗德岛,政策制定者可以使用药物过量数据针对高危亚人群,以减少过量伤害和死亡。罗德岛的研究可以与其他州分享。
无论药物类型如何,过量用药在罗德岛仍然是一场公共卫生危机。这是一种动态的流行,需要公共卫生、行为健康、公共安全、诊所、药房和社区之间的合作。实时跟踪药物过量的能力将是快速有效地应对罗德岛不断演变的药物过量流行的重要工具。